•
Jun 30, 2022

908 Devices Q2 2022 Earnings Report

Reported a 34% increase in revenue compared to the prior year, with a gross margin of 60%.

Key Takeaways

908 Devices reported an $11.1 million revenue for Q2 2022, a 34% increase year-over-year. The gross margin was 60%, and the company experienced a net loss of $8.1 million. They have acquired TRACE Analytics, expanding their bioanalytics platform.

Revenue for Q2 2022 was $11.1 million, a 34% increase compared to the prior year period.

Desktop revenue grew by 39% year-over-year driven by increased device sales and recurring revenue.

Gross profit for Q2 2022 was $6.6 million, with a gross margin of 60%.

Net loss for Q2 2022 was $8.1 million, or $0.26 per share.

Total Revenue
$11.1M
Previous year: $8.28M
+34.2%
EPS
-$0.26
Previous year: -$0.27
-3.7%
Installed Base
2.14K
Devices Placed
124
Gross Profit
$6.6M
Previous year: $4.38M
+50.7%
Cash and Equivalents
$213M
Previous year: $141M
+50.7%
Free Cash Flow
-$10.5M
Previous year: -$7.92M
+32.3%
Total Assets
$247M
Previous year: $166M
+48.4%

908 Devices

908 Devices

Forward Guidance

908 Devices continues to expect full year 2022 revenue to be in the range of $52 million to $55 million, representing 23% to 30% growth over full year 2021.